The bill, however, on the face of it, makes sense. We should try and avoid duplication and over-complicating processes, especially where they could have unintended consequences around the safety and environmental costs around delaying safer alternatives, and the continuation of use of not fit for purpose chemicals. Of course, we should be using relevant information from other international regulators instead of reinventing the wheel. Perhaps Pharmac might like to think about that also. We should be supporting an amendment that allows quicker and more efficient processing by the Environmental Protection Authority.